Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Shiga toxin is a potent cytotoxin produced by certain bacteria, most notably *Shigella dysenteriae* and Shiga toxin-producing *Escherichia coli* (STEC). It is responsible for severe gastrointestinal disease in humans, including bloody diarrhea and hemolytic uremic syndrome (HUS), a potentially fatal complication involving kidney failure. The toxin is an AB5-type exotoxin that binds to Gb3 glycolipids on host cells and inhibits protein synthesis, leading to cell death.
Inhibits protein synthesis via depurination of 28S rRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Shiga Toxin (None).